Diagnósticos da América S.A. Logo

Diagnósticos da América S.A.

DASA3.SA

(1.8)
Stock Price

2,98 BRL

-5.19% ROA

-11.29% ROE

-8.17x PER

Market Cap.

6.909.382.470,00 BRL

171.46% DER

0% Yield

-5.95% NPM

Diagnósticos da América S.A. Stock Analysis

Diagnósticos da América S.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Diagnósticos da América S.A. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.93x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

3 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

4 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

5 ROE

Negative ROE (-10.27%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-4.56%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 DER

The company has a high debt to equity ratio (166%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-208), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Diagnósticos da América S.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Diagnósticos da América S.A. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Diagnósticos da América S.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Diagnósticos da América S.A. Revenue
Year Revenue Growth
2005 528.280.000
2006 670.450.000 21.21%
2007 858.820.000 21.93%
2008 1.137.525.000 24.5%
2009 1.388.313.000 18.06%
2010 1.501.967.000 7.57%
2011 2.179.874.000 31.1%
2012 2.264.142.000 3.72%
2013 2.487.487.000 8.98%
2014 2.697.573.000 7.79%
2015 2.794.399.000 3.47%
2016 3.040.775.000 8.1%
2017 3.399.308.000 10.55%
2018 3.933.451.000 13.58%
2019 4.364.585.000 9.88%
2020 7.039.331.000 38%
2021 10.418.674.000 32.44%
2022 13.128.893.000 20.64%
2023 15.076.056.000 12.92%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Diagnósticos da América S.A. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Diagnósticos da América S.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 88.733.000
2006 151.061.000 41.26%
2007 171.587.000 11.96%
2008 211.474.000 18.86%
2009 302.287.000 30.04%
2010 266.555.000 -13.41%
2011 45.275.000 -488.75%
2012 148.118.000 69.43%
2013 196.565.000 24.65%
2014 149.470.000 -31.51%
2015 140.873.000 -6.1%
2016 141.184.000 0.22%
2017 231.046.000 38.89%
2018 344.771.000 32.99%
2019 337.258.000 -2.23%
2020 644.913.000 47.7%
2021 923.839.000 30.19%
2022 1.125.071.000 17.89%
2023 1.145.580.000 1.79%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Diagnósticos da América S.A. EBITDA
Year EBITDA Growth
2005 137.009.000
2006 189.811.000 27.82%
2007 219.249.000 13.43%
2008 862.214.000 74.57%
2009 252.768.000 -241.11%
2010 608.472.000 58.46%
2011 595.858.000 -2.12%
2012 400.022.000 -48.96%
2013 497.885.000 19.66%
2014 485.154.000 -2.62%
2015 440.369.000 -10.17%
2016 615.014.000 28.4%
2017 592.438.000 -3.81%
2018 612.704.000 3.31%
2019 867.650.000 29.38%
2020 774.378.000 -12.04%
2021 1.050.854.000 26.31%
2022 2.134.498.000 50.77%
2023 2.870.844.000 25.65%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Diagnósticos da América S.A. Gross Profit
Year Gross Profit Growth
2005 165.869.000
2006 226.974.000 26.92%
2007 274.226.000 17.23%
2008 1.137.525.000 75.89%
2009 444.891.000 -155.69%
2010 555.511.000 19.91%
2011 780.658.000 28.84%
2012 699.219.000 -11.65%
2013 772.850.000 9.53%
2014 840.508.000 8.05%
2015 768.403.000 -9.38%
2016 964.574.000 20.34%
2017 1.160.728.000 16.9%
2018 1.396.771.000 16.9%
2019 1.546.408.000 9.68%
2020 1.755.708.000 11.92%
2021 3.116.823.000 43.67%
2022 3.798.446.000 17.94%
2023 4.454.848.000 14.73%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Diagnósticos da América S.A. Net Profit
Year Net Profit Growth
2005 10.157.000
2006 16.511.000 38.48%
2007 56.621.000 70.84%
2008 -12.980.000 536.22%
2009 84.997.000 115.27%
2010 97.966.000 13.24%
2011 145.255.000 32.56%
2012 85.192.000 -70.5%
2013 131.301.000 35.12%
2014 82.289.000 -59.56%
2015 23.813.000 -245.56%
2016 94.738.000 74.86%
2017 131.443.000 27.92%
2018 184.378.000 28.71%
2019 124.777.000 -47.77%
2020 -147.739.000 184.46%
2021 -216.937.000 31.9%
2022 -387.766.000 44.05%
2023 -722.028.000 46.29%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Diagnósticos da América S.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 1 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -1 0%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Diagnósticos da América S.A. Free Cashflow
Year Free Cashflow Growth
2005 23.473.000
2006 5.056.000 -364.26%
2007 196.929.000 97.43%
2008 189.615.000 -3.86%
2009 13.246.000 -1331.49%
2010 69.378.000 80.91%
2011 -232.305.000 129.87%
2012 77.598.000 399.37%
2013 110.662.000 29.88%
2014 251.421.000 55.99%
2015 245.676.000 -2.34%
2016 512.538.000 52.07%
2017 398.818.000 -28.51%
2018 230.686.000 -72.88%
2019 194.617.000 -18.53%
2020 10.771.000 -1706.86%
2021 392.374.000 97.25%
2022 203.525.000 -92.79%
2023 -184.680.000 210.2%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Diagnósticos da América S.A. Operating Cashflow
Year Operating Cashflow Growth
2005 107.648.000
2006 132.873.000 18.98%
2007 383.383.000 65.34%
2008 338.606.000 -13.22%
2009 106.244.000 -218.71%
2010 195.293.000 45.6%
2011 -25.643.000 861.58%
2012 315.495.000 108.13%
2013 254.980.000 -23.73%
2014 459.222.000 44.48%
2015 494.329.000 7.1%
2016 841.937.000 41.29%
2017 653.235.000 -28.89%
2018 530.331.000 -23.17%
2019 699.366.000 24.17%
2020 766.504.000 8.76%
2021 1.298.179.000 40.96%
2022 1.339.682.000 3.1%
2023 -114.204.000 1273.06%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Diagnósticos da América S.A. Capital Expenditure
Year Capital Expenditure Growth
2005 84.175.000
2006 127.817.000 34.14%
2007 186.454.000 31.45%
2008 148.991.000 -25.14%
2009 92.998.000 -60.21%
2010 125.915.000 26.14%
2011 206.662.000 39.07%
2012 237.897.000 13.13%
2013 144.318.000 -64.84%
2014 207.801.000 30.55%
2015 248.653.000 16.43%
2016 329.399.000 24.51%
2017 254.417.000 -29.47%
2018 299.645.000 15.09%
2019 504.749.000 40.63%
2020 755.733.000 33.21%
2021 905.805.000 16.57%
2022 1.136.157.000 20.27%
2023 70.476.000 -1512.12%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Diagnósticos da América S.A. Equity
Year Equity Growth
2005 265.976.000
2006 469.206.000 43.31%
2007 512.380.000 8.43%
2008 478.902.000 -6.99%
2009 539.188.000 11.18%
2010 614.887.000 12.31%
2011 2.542.348.000 75.81%
2012 2.606.810.000 2.47%
2013 2.708.214.000 3.74%
2014 2.771.272.000 2.28%
2015 2.789.044.000 0.64%
2016 2.860.034.000 2.48%
2017 3.335.463.000 14.25%
2018 3.321.417.000 -0.42%
2019 3.263.382.000 -1.78%
2020 3.536.528.000 7.72%
2021 7.548.518.000 53.15%
2022 7.089.399.000 -6.48%
2023 7.943.780.000 10.76%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Diagnósticos da América S.A. Assets
Year Assets Growth
2005 585.129.000
2006 1.018.679.000 42.56%
2007 1.218.456.000 16.4%
2008 1.851.983.000 34.21%
2009 1.618.673.000 -14.41%
2010 1.944.939.000 16.78%
2011 4.282.796.000 54.59%
2012 4.272.175.000 -0.25%
2013 4.691.811.000 8.94%
2014 4.609.536.000 -1.78%
2015 4.681.796.000 1.54%
2016 5.124.727.000 8.64%
2017 6.246.487.000 17.96%
2018 7.223.593.000 13.53%
2019 8.839.181.000 18.28%
2020 13.343.496.000 33.76%
2021 23.249.904.000 42.61%
2022 26.844.191.000 13.39%
2023 27.093.749.000 0.92%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Diagnósticos da América S.A. Liabilities
Year Liabilities Growth
2005 318.799.000
2006 549.473.000 41.98%
2007 705.388.000 22.1%
2008 1.373.081.000 48.63%
2009 1.079.485.000 -27.2%
2010 1.330.052.000 18.84%
2011 1.740.776.000 23.59%
2012 1.664.983.000 -4.55%
2013 1.983.001.000 16.04%
2014 1.837.370.000 -7.93%
2015 1.891.846.000 2.88%
2016 2.263.683.000 16.43%
2017 2.926.539.000 22.65%
2018 3.902.176.000 25%
2019 5.575.799.000 30.02%
2020 9.806.968.000 43.14%
2021 15.701.386.000 37.54%
2022 19.754.792.000 20.52%
2023 19.149.969.000 -3.16%

Diagnósticos da América S.A. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
19.03
Net Income per Share
-1.13
Price to Earning Ratio
-8.17x
Price To Sales Ratio
0.49x
POCF Ratio
6.9
PFCF Ratio
141.85
Price to Book Ratio
0.87
EV to Sales
1.35
EV Over EBITDA
8.56
EV to Operating CashFlow
19.21
EV to FreeCashFlow
394.85
Earnings Yield
-0.12
FreeCashFlow Yield
0.01
Market Cap
6,91 Bil.
Enterprise Value
19,23 Bil.
Graham Number
16.46
Graham NetNet
-17.1

Income Statement Metrics

Net Income per Share
-1.13
Income Quality
-1.34
ROE
-0.11
Return On Assets
-0.03
Return On Capital Employed
0.05
Net Income per EBT
0.9
EBT Per Ebit
-0.9
Ebit per Revenue
0.07
Effective Tax Rate
0.09

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.29
Operating Profit Margin
0.07
Pretax Profit Margin
-0.07
Net Profit Margin
-0.06

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.15
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
1.34
Free CashFlow per Share
0.07
Capex to Operating CashFlow
-0.95
Capex to Revenue
-0.07
Capex to Depreciation
-0.79
Return on Invested Capital
0.04
Return on Tangible Assets
-0.05
Days Sales Outstanding
128.87
Days Payables Outstanding
48.69
Days of Inventory on Hand
17.43
Receivables Turnover
2.83
Payables Turnover
7.5
Inventory Turnover
20.94
Capex per Share
-1.28

Balance Sheet

Cash per Share
3,18
Book Value per Share
10,64
Tangible Book Value per Share
-3.84
Shareholders Equity per Share
10.64
Interest Debt per Share
20.73
Debt to Equity
1.71
Debt to Assets
0.5
Net Debt to EBITDA
5.49
Current Ratio
1.27
Tangible Asset Value
-2,87 Bil.
Net Current Asset Value
-11,01 Bil.
Invested Capital
1.71
Working Capital
1,73 Bil.
Intangibles to Total Assets
0.4
Average Receivables
2,51 Bil.
Average Payables
1,38 Bil.
Average Inventory
473675000
Debt to Market Cap
1.97

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Diagnósticos da América S.A. Dividends
Year Dividends Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 0 0%

Diagnósticos da América S.A. Profile

About Diagnósticos da América S.A.

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil.

CEO
Mr. Pedro de Godoy Bueno
Employee
18.142
Address
Av. JuruA, 434
Barueri, 06455-010

Diagnósticos da América S.A. Executives & BODs

Diagnósticos da América S.A. Executives & BODs
# Name Age
1 Mr. Carlos de Barros Jorge Neto Neto
General Director & Chief Investor Relations Officer
70
2 Mr. Licio Tavares Angelo Cintra
Chief Operations Officer
70
3 Mr. Andre Covre
Chief Financial & Administrative Officer
70
4 Mr. Adriano Brito da Costa Lima
Vice-President of Human Resources
70
5 Mr. Pedro de Godoy Bueno
Chief Executive Officer & MD
70
6 Mr. Emerson Leandro Gasparetto
Chief Radiology & Imaging Diagnosis Officer and Member of Management Board
70
7 Mr. Fábio Ferreira Cunha
Chief Legal & Compliance Officer
70
8 Mr. Glauco Desiderio
Investor Relations Officer
70

Diagnósticos da América S.A. Competitors

Rossi Residencial S.A. Logo
Rossi Residencial S.A.

RSID3.SA

(1.8)
CCR S.A. Logo
CCR S.A.

CCRO3.SA

(2.0)
Odontoprev S.A. Logo
Odontoprev S.A.

ODPV3.SA

(3.5)
CPFL Energia S.A. Logo
CPFL Energia S.A.

CPFE3.SA

(2.5)
Gafisa S.A. Logo
Gafisa S.A.

GFSA3.SA

(1.5)